On the relationship between conformation and stability in solid pharmaceutical protein formulations

Biotechnology Letters

Volumn 26, Issue 14, 2004, Pages 1103-1106

  Klibanov, Alexander M ^a   Schefiliti, Jennifer A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

albumin; FTIR; lyophilization; proteins; secondary structure

Indexed keywords

ALBUMINOID; DISULFIDE; THIOL DERIVATIVE;

ANIMAL; BIOTECHNOLOGY; CATTLE; CHEMISTRY; CONFORMATION; DRUG STABILITY; FREEZE DRYING; HUMAN; INFRARED SPECTROSCOPY; METHODOLOGY; PROTEIN CONFORMATION; SHORT SURVEY;

ALBUMINS; ANIMALS; BIOTECHNOLOGY; CATTLE; DISULFIDES; DRUG STABILITY; FREEZE DRYING; HUMANS; MOLECULAR CONFORMATION; PROTEIN CONFORMATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFHYDRYL COMPOUNDS;

BOVINAE;

EID: 3943077316     PISSN: 01415492     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BILE.0000035520.47933.a6     Document Type: Short Survey

References (20)

1. Ahern TJ, Manning MC, eds. (1992) Stability of Protein Pharmaceuticals. New York: Plenum Press.
2. Costantino HR, Langer R, Klibanov AM (1995) Aggregation of lyophilized pharmaceutical protein, recombinant human albumin: effect of moisture and stabilization by excipients. Bio/Technology 13: 493-496.
3. Desai UR, Osterhout JJ, Klibanov AM (1994) Protein structure in the lyophilized state: a hydrogen isotope exchange/NMR study with bovine pancreatic trypsin inhibitor. J. Am. Chem. Soc. 116: 9420-9422.
4. Griebenow K, Klibanov AM (1995) Lyophilization-induced reversible changes in the secondary structure of proteins. Proc. Natl. Acad. Sci. USA 92: 10969-10976.
5. He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358: 209-215.
6. Lai MC, Topp EM (1999) Solid-state stability of proteins and peptides. J. Pharm. Sci. 88: 489-500.
7. Liu WR, Langer R, Klibanov AM (1991) Moisture-induced aggregation of lyophilized proteins in the solid state. Biotechnol. Bioeng. 37: 177-184.
8. Peters Jr T (1996) All about Albumin. Biochemistry, Genetics and Medical Applications. San Diego: Academic Press.
9. Pikal MJ (1990a) Freeze-drying of proteins. Part I: Process design. BioPharm. 3(9): 18-27.
10. Pikal MJ (1990b) Freeze-drying of proteins. Part II: Formulation selection. BioPharm. 3(10): 26-30.
11. Prestegard JH (2001) High resolution NMR of biomolecules. In: Berthier C, Ljevy LP, Martinez G, eds. Lecture Notes in Physics, Vol. 595. Berlin: Springer-Verlag, pp. 426-434.
12. Robey FA, Tanaka T, Liu TY (1983) Isolation and characterization of two major serum proteins from the dogfish, Mustelus canis, C-reactive protein and amyloid P component. J. Biol. Chem. 258: 3889-3894.
13. Rouhi AM (2002) Generics next wave: biopharmaceuticals. Chem. Eng. News 80(38): 61-65.
14. Schmidt TS (2002) Banking on structures. Bio-IT World 1(8): 227065-227068.
15. Shenoy B, Wang Y, Shan W, Margolin AL (2001) Stability of crystalline proteins. Biotechnol. Bioeng. 73: 358-369.
16. Shnaible V, Wefing S, Resemann A, Suckau D, Bulcker A, Wolf-Kulmmeth S, Hoffmann D (2002) Screening for disulfide bonds in proteins by MALDI in-source decay and LIFT-TOF/TOF-MS. Anal Chem. 74: 4980-4988.
17. Struck MM (1994) Biopharmaceutical R&D success rates and development times. A new analysis provides benchmarks for the future. Bio/Technology 12: 674-677.
18. Torchinsky YM (1981) Sulfur in Proteins, Chapter 2. Oxford: Pergamon Press.
19. Wang W (2000) Lyophilization and development of solid protein pharmaceuticals. Int. J. Pharm. 203: 1-60.
20. Yeo S-D, Debenedetti PG, Patro SY, Przybycien TM (1994) Secondary structure characterization of microparticulate insulin powders J. Pharm. Sci. 83: 1651-1656.